181 related articles for article (PubMed ID: 20630585)
21. Tumor eradication in rat glioma and bypass of immunosuppressive barriers using internal radiation with (188)Re-lipid nanocapsules.
Vanpouille-Box C; Lacoeuille F; Belloche C; Lepareur N; Lemaire L; LeJeune JJ; Benoît JP; Menei P; Couturier OF; Garcion E; Hindré F
Biomaterials; 2011 Oct; 32(28):6781-90. PubMed ID: 21705077
[TBL] [Abstract][Full Text] [Related]
22. Development of 2D and 3D mucus models and their interactions with mucus-penetrating paclitaxel-loaded lipid nanocapsules.
Groo AC; Mircheva K; Bejaud J; Ailhas C; Panaiotov I; Saulnier P; Ivanova T; Lagarce F
Pharm Res; 2014 Jul; 31(7):1753-65. PubMed ID: 24469905
[TBL] [Abstract][Full Text] [Related]
23. Self-assembled core-shell vascular-targeted nanocapsules for temporal antivasculature and anticancer activities.
Wang Z; Ho PC
Small; 2010 Nov; 6(22):2576-83. PubMed ID: 20976704
[TBL] [Abstract][Full Text] [Related]
24. High cytotoxicity of cisplatin nanocapsules in ovarian carcinoma cells depends on uptake by caveolae-mediated endocytosis.
Hamelers IH; Staffhorst RW; Voortman J; de Kruijff B; Reedijk J; van Bergen en Henegouwen PM; de Kroon AI
Clin Cancer Res; 2009 Feb; 15(4):1259-68. PubMed ID: 19228729
[TBL] [Abstract][Full Text] [Related]
25. Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition.
Lamprecht A; Benoit JP
J Control Release; 2006 May; 112(2):208-13. PubMed ID: 16574265
[TBL] [Abstract][Full Text] [Related]
26. Lipid nanocapsules: a new platform for nanomedicine.
Huynh NT; Passirani C; Saulnier P; Benoit JP
Int J Pharm; 2009 Sep; 379(2):201-9. PubMed ID: 19409468
[TBL] [Abstract][Full Text] [Related]
27. Effect of O/S/W process parameters on 17beta-EV loaded nanoparticles properties.
Khoee S; Hossainzadeh MT
Colloids Surf B Biointerfaces; 2010 Jan; 75(1):133-40. PubMed ID: 19740631
[TBL] [Abstract][Full Text] [Related]
28. Preparation and Optimization Lipid Nanocapsules to Enhance the Antitumor Efficacy of Cisplatin in Hepatocellular Carcinoma HepG2 Cells.
Zhai Q; Li H; Song Y; Wu R; Tang C; Ma X; Liu Z; Peng J; Zhang J; Tang Z
AAPS PharmSciTech; 2018 Jul; 19(5):2048-2057. PubMed ID: 29679292
[TBL] [Abstract][Full Text] [Related]
29. Silencing of miR-21 by locked nucleic acid-lipid nanocapsule complexes sensitize human glioblastoma cells to radiation-induced cell death.
Griveau A; Bejaud J; Anthiya S; Avril S; Autret D; Garcion E
Int J Pharm; 2013 Oct; 454(2):765-74. PubMed ID: 23732394
[TBL] [Abstract][Full Text] [Related]
30. A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy.
Zhang L; Tian B; Li Y; Lei T; Meng J; Yang L; Zhang Y; Chen F; Zhang H; Xu H; Zhang Y; Tang X
ACS Appl Mater Interfaces; 2015 Nov; 7(45):25147-61. PubMed ID: 26501354
[TBL] [Abstract][Full Text] [Related]
31. Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules.
Simonsson C; Bastiat G; Pitorre M; Klymchenko AS; Béjaud J; Mély Y; Benoit JP
Eur J Pharm Biopharm; 2016 Jan; 98():47-56. PubMed ID: 26522878
[TBL] [Abstract][Full Text] [Related]
32. Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model.
Allard E; Huynh NT; Vessières A; Pigeon P; Jaouen G; Benoit JP; Passirani C
Int J Pharm; 2009 Sep; 379(2):317-23. PubMed ID: 19467309
[TBL] [Abstract][Full Text] [Related]
33. siRNA LNCs--a novel platform of lipid nanocapsules for systemic siRNA administration.
David S; Resnier P; Guillot A; Pitard B; Benoit JP; Passirani C
Eur J Pharm Biopharm; 2012 Jun; 81(2):448-52. PubMed ID: 22381204
[TBL] [Abstract][Full Text] [Related]
34. Electrokinetic properties of noncharged lipid nanocapsules: influence of the dipolar distribution at the interface.
Vonarbourg A; Saulnier P; Passirani C; Benoit JP
Electrophoresis; 2005 Jun; 26(11):2066-75. PubMed ID: 15852355
[TBL] [Abstract][Full Text] [Related]
35. The gastrointestinal stability of lipid nanocapsules.
Roger E; Lagarce F; Benoit JP
Int J Pharm; 2009 Sep; 379(2):260-5. PubMed ID: 19524655
[TBL] [Abstract][Full Text] [Related]
36. Lipid nanocapsules for transdermal delivery of ropivacaine: in vitro and in vivo evaluation.
Zhai Y; Yang X; Zhao L; Wang Z; Zhai G
Int J Pharm; 2014 Aug; 471(1-2):103-11. PubMed ID: 24858383
[TBL] [Abstract][Full Text] [Related]
37. DNA amplification via polymerase chain reaction inside miniemulsion droplets with subsequent poly(n-butylcyanoacrylate) shell formation and delivery of polymeric capsules into mammalian cells.
Baier G; Musyanovych A; Landfester K; Best A; Lorenz S; Mailänder V
Macromol Biosci; 2011 Aug; 11(8):1099-109. PubMed ID: 21557476
[TBL] [Abstract][Full Text] [Related]
38. Development and in vitro evaluations of new decitabine nanocarriers for the treatment of acute myeloid leukemia.
Briot T; Roger E; Lautram N; Verger A; Clavreul A; Lagarce F
Int J Nanomedicine; 2017; 12():8427-8442. PubMed ID: 29200853
[TBL] [Abstract][Full Text] [Related]
39. Radiolabeling and targeting of lipidic nanocapsules for applications in radioimmunotherapy.
Jestin E; Mougin-Degraef M; Faivre-Chauvet A; Remaud-Le Saëc P; Hindre F; Benoit JP; Chatal JF; Barbet J; Gestin JF
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):51-60. PubMed ID: 17372573
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial targeting by use of lipid nanocapsules loaded with SV30, an analogue of the small-molecule Bcl-2 inhibitor HA14-1.
Weyland M; Manero F; Paillard A; Grée D; Viault G; Jarnet D; Menei P; Juin P; Chourpa I; Benoit JP; Grée R; Garcion E
J Control Release; 2011 Apr; 151(1):74-82. PubMed ID: 21138749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
